drugset / Trial / NCT05414006

Effect of S-ketamine in Cesarean Section Combined Anesthesia

NCT05414006

RandomizedCrossoverTriple-blindPrevention

Summary

To compare the anti-hyperalgesia effect between S-ketamine with placebo for Maternal receiving elective Cesarean Section under Combined spinal and epidural analgesia. Based on this study the investigators intend to verify the role and potential mechanism of S-ketamine combined anesthesia in alleviating hyperalgesia after cesarean section, prove that it can reduce hyperalgesia and postoperative pain. explore the role of S-ketamine in alleviating postoperative hyperalgesia in different PCA ways and explore the safety of S-ketamine in the perilactation

Timeline

Start
2022-06-14
Primary completion
2022-08-31
Completion
2022-09-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Esketamine Other / unclassified 0.1 mg/kg Intravenous

Indications

No indication recorded.